Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-26

FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) to expand the label for the treatment of urticaria (hives), manufactured by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYRTEC HIVES (cetirizine hydrochloride)

Snippet

SUPPL AP for ZYRTEC HIVES (CETIRIZINE HYDROCHLORIDE)